| Literature DB >> 26231115 |
Tal Capucha1, Gabriel Mizraji1, Hadas Segev1, Ronnie Blecher-Gonen2, Deborah Winter2, Abed Khalaileh3, Yaara Tabib1, Tsipora Attal1, Maria Nassar1, Katya Zelentsova1, Hen Kisos1, Martin Zenke4, Kristin Seré4, Thomas Hieronymus4, Tal Burstyn-Cohen1, Ido Amit2, Asaf Wilensky5, Avi-Hai Hovav6.
Abstract
Langerhans cells (LCs) populate the mucosal epithelium, a major entry portal for pathogens, yet their ontogeny remains unclear. We found that, in contrast to skin LCs originating from self-renewing radioresistant embryonic precursors, oral mucosal LCs derive from circulating radiosensitive precursors. Mucosal LCs can be segregated into CD103(+)CD11b(lo) (CD103(+)) and CD11b(+)CD103(-) (CD11b(+)) subsets. We further demonstrated that similar to non-lymphoid dendritic cells (DCs), CD103(+) LCs originate from pre-DCs, whereas CD11b(+) LCs differentiate from both pre-DCs and monocytic precursors. Despite this ontogenetic discrepancy between skin and mucosal LCs, the transcriptomic signature and immunological function of oral LCs highly resemble those of skin LCs but not DCs. These findings, along with the epithelial position, morphology, and expression of the LC-associated phenotype strongly suggest that oral mucosal LCs are genuine LCs. Collectively, in a tissue-dependent manner, murine LCs differentiate from at least three distinct precursors (embryonic, pre-DC, and monocytic) in steady state.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26231115 DOI: 10.1016/j.immuni.2015.06.017
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745